Phosphostim-activated gamma delta T cells kill autologous metastatic renal cell carcinoma.
about
The Role of γδ T Cells in Systemic Lupus ErythematosusNKG2D ligands as therapeutic targetsγδ T cells in cancer immunotherapySelf/non-self discrimination by human gammadelta T cells: simple solutions for a complex issue?Identification of human T cell receptor gammadelta-recognized epitopes/proteins via CDR3delta peptide-based immunobiochemical strategy.DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells.NK cells and gammadelta T cells mediate resistance to polyomavirus-induced tumors.Aminobisphosphonate-pretreated dendritic cells trigger successful Vgamma9Vdelta2 T cell amplification for immunotherapy in advanced cancer patients.The feature of distribution and clonality of TCR γ/δ subfamilies T cells in patients with B-cell non-Hodgkin lymphoma.Signal transduction by different forms of the γδ T cell-specific pattern recognition receptor WC1.Sensitization of ovarian carcinoma cells with zoledronate restores the cytotoxic capacity of Vγ9Vδ2 T cells impaired by the prostaglandin E2 immunosuppressive factor: implications for immunotherapy.Full restoration of Brucella-infected dendritic cell functionality through Vγ9Vδ2 T helper type 1 crosstalk.γδ T cells cross-link innate and adaptive immunity in Mycobacterium tuberculosis infection.Immune therapy for breast cancer in 2010-hype or hope?Preferential Th1 cytokine profile of phosphoantigen-stimulated human Vγ9Vδ2 T cells.γδ T-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibody.Histological Analysis of γδ T Lymphocytes Infiltrating Human Triple-Negative Breast Carcinomas.Rapamycin increases the yield and effector function of human γδ T cells stimulated in vitro.Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours.Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma.Ectopically expressed human tumor biomarker MutS homologue 2 is a novel endogenous ligand that is recognized by human γδ T cells to induce innate anti-tumor/virus immunity.Hepatocellular carcinoma cell sensitivity to Vγ9Vδ2 T lymphocyte-mediated killing is increased by zoledronateTumor-infiltrating γδ T lymphocytes predict clinical outcome in human breast cancer.Human gamma delta T cells: candidates for the development of immunotherapeutic strategies.Isopentenyl pyrophosphate-activated CD56+ {gamma}{delta} T lymphocytes display potent antitumor activity toward human squamous cell carcinoma.Phenotypic and functional alterations of Vgamma2Vdelta2 T cell subsets in patients with active nasopharyngeal carcinoma.Harnessing innate and adaptive immunity for adoptive cell therapy of renal cell carcinoma.Questionable relevance of gamma delta T lymphocytes in renal cell carcinomaγδ T cells and their potential for immunotherapy.Repertoire development and the control of cytotoxic/effector function in human gammadelta T cells.Immunotherapy targeting colon cancer stem cells.New advances in leukaemia immunotherapy by the use of Chimeric Artificial Antigen Receptors (CARs): state of the art and perspectives for the near future.Role of gamma-delta T-cells in cancer: another opening door to immunotherapy.Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedside.At the Bedside: Innate immunity as an immunotherapy tool for hematological malignancies.T-cell-associated cellular immunotherapy for lung cancer.Cancer Immunotherapy Using γδT Cells: Dealing with Diversity.Tumor-Infiltrating γδ T Lymphocytes: Pathogenic Role, Clinical Significance, and Differential Programing in the Tumor Microenvironment.The Jekyll and Hyde story of IL17-Producing γδT Cells.Exploiting natural killer group 2D receptors for CAR T-cell therapy.
P2860
Q26765027-0FC2FB9F-E4E4-463A-B129-CFB78A8DB772Q27014888-1490D0DC-3A48-4B9C-8104-82DA0F3620DEQ28068988-E48D65DF-70D1-42FA-939A-2FCF586B4C2EQ28287583-45112743-9D69-4A37-891D-99F3EA820581Q33322644-3768A564-A089-42F0-94CC-5EB49EFB5A71Q33436859-54780D46-F430-4A69-84E7-ADE7D8A98218Q33594446-6797396A-F97D-479A-88A7-81247DE2A2ABQ33617841-14C51FDF-3E7C-4F5C-85E2-ED95C8647164Q33747619-66A8F58E-5863-46B5-B5D0-3C35E6E011A1Q33795825-98C611BF-E242-4B7F-B53F-C59CF6CB31DAQ34077388-43C4C7B6-0156-48F5-8FC9-09DC3A3E498EQ34395849-5AAB3D2D-986B-4932-A728-6446B35EE9B5Q34496948-365FC6B8-7CE7-432F-8742-AE0DBD89A7BBQ34541467-C23F6F0E-42DB-497E-82FA-F29EBA82EA3AQ34595188-FAD64D87-090E-4949-9B58-A5054A9D761DQ34612619-6FCD32D7-E7F1-4D83-B421-A2361C7F7ECEQ34668723-BB4B60CE-E2C0-45D4-8496-1A2323F510B7Q34802235-D0DEC777-FD66-43C3-AC1F-961E6465BA86Q35208161-44F5B839-431D-4D86-9CB3-53910ED6545CQ35226178-16D616AF-E889-442A-9FE3-7BA9C76F36DBQ35956512-D757BBFC-97F9-43EC-BADB-AFAA8B23D3B4Q36734208-D089FD8D-4124-44BC-8F2F-9BFB8EE7D293Q36800215-C3422BC4-91ED-48D3-A479-462C8E1F80ABQ36908780-3A953A12-4472-4860-9665-10FAAD2C8F2FQ37038276-5CC9B5DD-6DCB-4563-8971-3555A3F2D03EQ37226209-CF67153D-FD70-4B15-807C-5B445875D85CQ37409283-CB051D36-1BCC-44F4-82E9-1506D5E873BFQ37473297-2BAC152A-7B70-44ED-BCFD-3FACBE6A2013Q37576001-2AC439DC-DF04-4EAB-8A45-9B7906106031Q37731978-F0CEC905-69F1-4BB5-AACD-A62A2652E4ACQ37822747-C55E1874-D46C-4FCF-BC23-BF09AD29BACCQ37937083-91B8BF10-ACF2-4115-96F6-A918C06CFA8BQ38051222-5E667BCC-B84E-41DE-AC3B-9CA91586EEBAQ38051730-C8FB856B-23F9-41FA-819B-3CBBA13E7228Q38149725-7AF62E33-D8E5-4737-BBB9-ADB75EC5DB3BQ38266198-B2996BB2-D2F6-4842-88A0-ACF9840A4E0CQ38283536-C4E464CC-C682-432D-B109-E80FA3F6D093Q38287973-594F4639-8C1E-49CF-95BB-91AFD491D1FAQ38362640-8CB82DF8-99F2-4705-8FB0-39B0920F13ADQ38671184-FDF4FE40-298E-4858-A906-F089F3314049
P2860
Phosphostim-activated gamma delta T cells kill autologous metastatic renal cell carcinoma.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Phosphostim-activated gamma de ...... tastatic renal cell carcinoma.
@en
type
label
Phosphostim-activated gamma de ...... tastatic renal cell carcinoma.
@en
prefLabel
Phosphostim-activated gamma de ...... tastatic renal cell carcinoma.
@en
P2093
P1476
Phosphostim-activated gamma de ...... tastatic renal cell carcinoma.
@en
P2093
Emilie Viey
Gaëlle Fromont
Salem Chouaib
Sylvie Da Rocha
Yannis Morel
P304
P356
10.4049/JIMMUNOL.174.3.1338
P407
P577
2005-02-01T00:00:00Z